Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07691242
PHASE1
Multiple Ascending Dose Study of DW4421
Sponsor: Daewon Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
Multiple Ascending Dose of DW4421, phase I
Official title: A Phase 1 Clinical Trial to Evaluate the Safety, the Pharmacokinetics and Pharmacodynamics After Multiple Administration of DW4421 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2026-09
Completion Date
2027-02
Last Updated
2026-07-08
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DW4421S-T0
DW4421 5mg
DRUG
DW4421S-T2
DW4421 15mg
DRUG
DW4421S-T1
DW4421 20mg
DRUG
DW4421S-T3
DW4421 30mg
DRUG
DW4421S
DW4421 40mg
DRUG
DW4421-3
Zastaprazan 20mg
Locations (1)
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea